These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 36434912)

  • 21. The impact of structural bioinformatics tools and resources on SARS-CoV-2 research and therapeutic strategies.
    Waman VP; Sen N; Varadi M; Daina A; Wodak SJ; Zoete V; Velankar S; Orengo C
    Brief Bioinform; 2021 Mar; 22(2):742-768. PubMed ID: 33348379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural basis for the interaction of SARS-CoV-2 virulence factor nsp1 with DNA polymerase α-primase.
    Kilkenny ML; Veale CE; Guppy A; Hardwick SW; Chirgadze DY; Rzechorzek NJ; Maman JD; Pellegrini L
    Protein Sci; 2022 Feb; 31(2):333-344. PubMed ID: 34719824
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.
    Guo YR; Cao QD; Hong ZS; Tan YY; Chen SD; Jin HJ; Tan KS; Wang DY; Yan Y
    Mil Med Res; 2020 Mar; 7(1):11. PubMed ID: 32169119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification of intrinsically disorder regions in non-structural proteins of SARS-CoV-2: New insights into drug and vaccine resistance.
    Anjum F; Mohammad T; Asrani P; Shafie A; Singh S; Yadav DK; Uversky VN; Hassan MI
    Mol Cell Biochem; 2022 May; 477(5):1607-1619. PubMed ID: 35211823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Newly Emerged Antiviral Strategies for SARS-CoV-2: From Deciphering Viral Protein Structural Function to the Development of Vaccines, Antibodies, and Small Molecules.
    Zhang C; Yang M
    Int J Mol Sci; 2022 May; 23(11):. PubMed ID: 35682761
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A perspective on potential target proteins of COVID-19: Comparison with SARS-CoV for designing new small molecules.
    Kumar D; Chauhan G; Kalra S; Kumar B; Gill MS
    Bioorg Chem; 2020 Nov; 104():104326. PubMed ID: 33142431
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An outlook on potential protein targets of COVID-19 as a druggable site.
    Noori R; Sardar M
    Mol Biol Rep; 2022 Nov; 49(11):10729-10748. PubMed ID: 35790657
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Overview of SARS-CoV-2 genome-encoded proteins.
    Bai C; Zhong Q; Gao GF
    Sci China Life Sci; 2022 Feb; 65(2):280-294. PubMed ID: 34387838
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pathogenesis-directed therapy of 2019 novel coronavirus disease.
    Stratton CW; Tang YW; Lu H
    J Med Virol; 2021 Mar; 93(3):1320-1342. PubMed ID: 33073355
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design and Evaluation of Anti-SARS-Coronavirus Agents Based on Molecular Interactions with the Viral Protease.
    Akaji K; Konno H
    Molecules; 2020 Aug; 25(17):. PubMed ID: 32867349
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diversity in the Accessory Proteins of SARS-CoV-2, SARS-CoV, and MERS-CoV Betacoronaviruses.
    Cruz CAK; Medina PMB
    Curr Protein Pept Sci; 2021; 22(10):695-715. PubMed ID: 34514989
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), a newly emerged pathogen: an overview.
    Rathore JS; Ghosh C
    Pathog Dis; 2020 Aug; 78(6):. PubMed ID: 32840560
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mapping SARS-CoV-2 Antibody Epitopes in COVID-19 Patients with a Multi-Coronavirus Protein Microarray.
    Camerini D; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Shandling A; Huynh V; Teng AA; Hermanson G; Pablo JV; Stumpf MM; Lester SN; Harcourt J; Tamin A; Rasheed M; Thornburg NJ; Satheshkumar PS; Liang X; Kennedy RB; Yee A; Townsend M; Campo JJ
    Microbiol Spectr; 2021 Oct; 9(2):e0141621. PubMed ID: 34704808
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine.
    Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L
    Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The genetic sequence, origin, and diagnosis of SARS-CoV-2.
    Wang H; Li X; Li T; Zhang S; Wang L; Wu X; Liu J
    Eur J Clin Microbiol Infect Dis; 2020 Sep; 39(9):1629-1635. PubMed ID: 32333222
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glycosylated, Lipid-Binding, CDR-Like Domains of SARS-CoV-2 ORF8 Indicate Unique Sites of Immune Regulation.
    Wu F; Chen X; Ma Y; Wu Y; Li R; Huang Y; Zhang R; Zhou Y; Zhan J; Liu S; Xu W
    Microbiol Spectr; 2023 Aug; 11(4):e0123423. PubMed ID: 37318366
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19).
    Shanmugaraj B; Siriwattananon K; Wangkanont K; Phoolcharoen W
    Asian Pac J Allergy Immunol; 2020 Mar; 38(1):10-18. PubMed ID: 32134278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of the GTNGTKR motif in the N-terminal receptor-binding domain of the SARS-CoV-2 spike protein.
    Behloul N; Baha S; Shi R; Meng J
    Virus Res; 2020 Sep; 286():198058. PubMed ID: 32531235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3-chymotrypsin-like protease in SARS-CoV-2.
    Al Adem K; Ferreira JC; Villanueva AJ; Fadl S; El-Sadaany F; Masmoudi I; Gidiya Y; Gurudza T; Cardoso THS; Saksena NK; Rabeh WM
    Biosci Rep; 2024 Aug; 44(8):. PubMed ID: 39036877
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.